Definitive Healthcare Corp. (NASDAQ:DH) Shares Sold by M&T Bank Corp

M&T Bank Corp cut its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 49.4% in the third quarter, HoldingsChannel.com reports. The fund owned 49,131 shares of the company’s stock after selling 48,006 shares during the period. M&T Bank Corp’s holdings in Definitive Healthcare were worth $220,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Point72 DIFC Ltd raised its stake in Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock valued at $42,000 after purchasing an additional 8,215 shares during the last quarter. Intech Investment Management LLC acquired a new stake in shares of Definitive Healthcare in the third quarter valued at about $55,000. Sanctuary Advisors LLC purchased a new position in shares of Definitive Healthcare in the second quarter worth about $85,000. Bleakley Financial Group LLC acquired a new position in Definitive Healthcare during the third quarter worth about $74,000. Finally, Glenmede Trust Co. NA grew its stake in Definitive Healthcare by 41.1% during the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock valued at $82,000 after acquiring an additional 5,362 shares in the last quarter. 98.67% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on DH shares. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. BTIG Research started coverage on Definitive Healthcare in a research report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $5.81.

Definitive Healthcare Price Performance

DH opened at $4.14 on Friday. The firm has a market cap of $478.27 million, a price-to-earnings ratio of -1.34, a PEG ratio of 3.29 and a beta of 1.40. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. The stock’s 50-day moving average price is $4.42 and its 200 day moving average price is $4.70. Definitive Healthcare Corp. has a 12-month low of $3.19 and a 12-month high of $10.62.

Insider Buying and Selling

In other news, insider William Moschella sold 45,000 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the sale, the insider now directly owns 433,830 shares in the company, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 14.84% of the stock is currently owned by insiders.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.